FDANonrulemakingFDA-2023-N-0743
Who commented on this docket
Using Artificial Intelligence and Machine Learning in the Development of Drug and Biological Products; Availability
3 organizations filed 4 public comments on Using Artificial Intelligence and Machine Learning in the Development of Drug and Biological Products; Availability, at the Food and Drug Administration. The comment window closed 1084d ago.
Organizations
3
Comments
4
RIN
—
Comment window
closed 1084d ago
Abstract
OPEN
Commenters (3)
- National Federation of Independent Businesstrade assoc.2 filings · confidence 97%
- Association for Accessible Medicinestrade assoc.1 filing · confidence 97%
- Parenteral Drug Associationtrade assoc.1 filing · confidence 97%
Attribution is name-based and imperfect. regulations.gov data is public record.